- Home
- XERS vs OSBC Comparison
XERS vs OSBC Comparison
Compare XERS & OSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XERS | OSBC |
|---|---|---|
| Founded | 2005 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 936.3M | 1.0B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | XERS | OSBC |
|---|---|---|
| Price | $5.48 | $19.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | $10.83 | ★ $22.63 |
| AVG Volume (30 Days) | ★ 2.1M | 318.0K |
| Earning Date | 03-02-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.43% |
| EPS Growth | ★ 100.00 | N/A |
| EPS | N/A | ★ 1.62 |
| Revenue | ★ $49,590,000.00 | N/A |
| Revenue This Year | $28.65 | $25.15 |
| Revenue Next Year | $18.33 | $3.21 |
| P/E Ratio | ★ N/A | $12.10 |
| Revenue Growth | ★ 142.67 | N/A |
| 52 Week Low | $3.81 | $14.21 |
| 52 Week High | $10.08 | $22.00 |
Technical Indicators
Market Signals| Indicator | XERS | OSBC |
|---|---|---|
| Relative Strength Index (RSI) | 32.82 | 42.89 |
| Support Level | $4.30 | $19.20 |
| Resistance Level | $5.49 | $21.33 |
| Average True Range (ATR) | 0.24 | 0.52 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 12.43 | 33.61 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
About OSBC Old Second Bancorp Inc.
Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.